There is no conclusive evidence that the combination of atorvastatin and ezetimibe increases the risk of cancer. Both medications are commonly prescribed for cholesterol management, and clinical studies have not shown a direct link between their use and cancer development. However, as with any medication, it is essential to discuss potential risks and benefits with a healthcare provider, especially if there are concerns about cancer or other health issues. Regular monitoring and follow-up are important for individuals on these medications.
Copyright © 2026 eLLeNow.com All Rights Reserved.